skip to Main Content
Bonjour, | Log in
  • Français

Offer

Breast cancer offer

Predilife presents MammoRisk®

The first breast cancer risk prediction solution in France

Since 2019, Predilife has been marketing MammoRisk®, the first breast cancer risk prediction solution in France offering women a clear report for personalised screening..

The MammoRisk® test integrates the latest scientific knowledge in terms of risk factors (clinical data, imaging and medical biology) in order to provide to each woman a unique and adapted monitoring.

Today, all women from 40 years of age can request a risk consultation from their doctor and have their breast cancer risk assessment.

Want to know more
on MammoRisk®

Back To Top